SlideShare a Scribd company logo
Environmental Monitoring
Viable Airborne Particle Testing
Environmental viable airborne particle
testing is part of a good environmental
sampling (ES) program designed to ensure
that compounding area(s) maintain
acceptably low viable particle levels.
Your sampling plan for viable airborne testing
should include sampling locations, collection
methods, frequency, air volume to test, time
of day testing will occur, and action levels
Sampling for airborne viable particles must
be conducted based on a risk assessment of
your facilities compounding activities
However, testing must occur at a minimum
every 6 months in all compounding areas
(PECs, buffer areas, ante areas, and areas
adjacent to segregated compounding areas)
as part of the recertification process
Viable air sampling may be performed by
properly training in-house personnel, or may
be contracted to a qualified third party.
Sampling must include multiple locations
within each ISO Class 5 environment (PECs)
and in the secondary engineering controls
(ISO Class 7 buffer areas and ISO Class 8 ante-
areas)
Sampling must also be performed in
segregated compounding areas at greatest
risk of contamination (e.g., work areas near
the ISO Class 5 environment, counters near
doors, pass-through boxes, and so on)
For low-, medium-, and high-risk level
compounding, air sampling shall be
performed at locations that are prone to
contamination during compounding activities
and during other activities such as staging,
labeling, gowning, and cleaning.
Locations must include zones of air backwash
turbulence within laminar airflow
workbenches (LAFW) and other areas where
air backwash turbulence may enter the
compounding area (doorways, in and around
ISO Class 5 primary engineering control and
environments)
For low-risk level CSPs with 12-hour or less
BUD prepared in an aseptic isolator located
outside of a clean room that maintains an
ISO Class 5 area in its interior, perform air
sampling at locations inside the ISO Class 5
environment and other areas in close
proximity to the ISO Class 5 environment
It’s important when performing viable
particle sampling to use both an appropriate
collection method as well as an appropriate
growth medium
active air sampling to
be performed using a
volumetric impaction
sampler.
USP Chapter <797> calls for:
*or other suitable media that supports the growth of fungi
use of 2 media for air
sampling: Soybean–
Casein Digest Medium for
bacteria and malt extract
agar* for fungi in high-risk
compounding areas
Volumetric impaction samplers
use a solid or adhesive medium,
such as agar, for particle
collection. Air is drawn into a
sampler and accelerated,
producing laminar air flow onto
the collection surface (agar plate
or contact plate filled with a
suitable agar medium)
Active sampling means that air samples are
collected under working conditions, i.e. while
compounding is taking pace
It is suggested that the volume of air sampled
be between 400mL and 1L*
*subject to recommendations by the manufacturer of the sampling device and volume needed to meet limits of detection for ISO rating of area tested
At the end of the air sampling activities, the
microbial growth media plates are recovered
and their covers are taped closed, and they
are inverted and incubated at a temperature
and period of time conducive to
multiplication of microorganisms
The TSA (a.k.a. Soybean-Casein Digest Agar
Medium) used to test for bacteria should be
incubated at 30°C to 35°C (86°F - 95°F) for 48
to 72 hours
The Malt Extract Agar - or other suitable
fungal media - should be incubated at 26°C
to 30°C (79°F - 86°F) for 5 to 7 days
*
Growth media should be incubated outside
the sterile prep area according to the
manufacturer's recommendations
Following incubation, the number of discrete
colonies of microorganisms are counted and
reported as colony-forming unit (cfu) per cubic
meter (1000mL) of air and documented on an
environmental sampling form
CFU is a unit used
to estimate the
number of viable
bacteria or fungal
cells in a sample
Action levels are determined on the basis of
cfu data gathered at each sampling location
and trended over time
However, regardless of cfu count, the growth of
highly pathogenic microorganisms1 must be
immediately remedied with the assistance of a
competent microbiologist, infection control
professional or industrial hygienist
1. Gram-negative rods, coagulase positive staphylococcus, molds and yeasts can be potentially fatal to patients receiving CSPs
Action levels for cfu count are listed below in Table 2
Table 2 adopted from: The United States Pharmacopeia, 37th rev., and The national formulary, 32nd ed. USP General Chapter <797>. Pharmaceutical Compounding - Sterile Preparations. Rockville, MD: The
United States Pharmacopeial Convention; 2014.
Any cfu count that exceeds its action level
should prompt a re-evaluation of the
adequacy of personnel work practices,
cleaning procedures, operational procedures,
and air filtration efficiency within the aseptic
compounding location.
Sources of contamination may include HVAC
systems, damaged HEPA filters, and changes
in personnel garbing or work practices.
Areas exceeding action levels should be
remediated back into compliance
Review
results
Analyze lab data
Compare to
established
levels
Review
organisms
recovered
Investigate
cause
Establish
corrective
actions
Eliminate
Problem
Clean area and
resample
Implement
procedures to
prevent
reoccurrence
If an activity consistently shows elevated
levels of microbial growth following
corrective action, competent microbiology
personnel should be consulted
JERRY FAHRNI, PHARM.D.

More Related Content

PPTX
Environmental monitoring - Introduction
PPTX
Environmental monitoring - nonviable particle testing
PPT
ENVIRONMENTAL MONITORING
PPT
Control on Cleanroom Environmental Monitoring (Pharmaceutical)
PPTX
Environmental Monitoring of Clean Room
PPT
Media fill process and validation
PDF
Microbiological Environmental Monitoring in Pharmaceutical Facility
PPT
Environmental monitoring
Environmental monitoring - Introduction
Environmental monitoring - nonviable particle testing
ENVIRONMENTAL MONITORING
Control on Cleanroom Environmental Monitoring (Pharmaceutical)
Environmental Monitoring of Clean Room
Media fill process and validation
Microbiological Environmental Monitoring in Pharmaceutical Facility
Environmental monitoring

What's hot (20)

PPT
Risk analysis in sterile operation
PPT
Risk Issues Environmental Monitoring of Cleanrooms
PDF
Aseptic Processing & Media Fill
PPTX
Microbiology Laboratory Qualifications and Microbial Testing Techniques
PPTX
ISO 14644-1
PPTX
USP &lt;1116> and its impact on Microbiology
PPTX
Media fill validation ppt (1)
PPT
Handling OOS results
PDF
Usp 36 Chapter 1116 environment monitoring
PPTX
Environmental monitoring - surface sampling
PDF
Cleaning Validation in Pharma Industry.pdf
PPTX
Auditing of microbiology laboratory
PPTX
Cleaning validation
PDF
Introduction to Pharmaceutical Microbiology
PPTX
Good Aseptic Practices ppt
PDF
Effective Use of Environmental Monitoring Data Trending
PDF
Cleanroom Qualification
PPT
Clean Room_Presentation
PPT
Presentation on-hold-time-study
Risk analysis in sterile operation
Risk Issues Environmental Monitoring of Cleanrooms
Aseptic Processing & Media Fill
Microbiology Laboratory Qualifications and Microbial Testing Techniques
ISO 14644-1
USP &lt;1116> and its impact on Microbiology
Media fill validation ppt (1)
Handling OOS results
Usp 36 Chapter 1116 environment monitoring
Environmental monitoring - surface sampling
Cleaning Validation in Pharma Industry.pdf
Auditing of microbiology laboratory
Cleaning validation
Introduction to Pharmaceutical Microbiology
Good Aseptic Practices ppt
Effective Use of Environmental Monitoring Data Trending
Cleanroom Qualification
Clean Room_Presentation
Presentation on-hold-time-study
Ad

Viewers also liked (20)

PPTX
Environmental monitoring
PPTX
A Risk-Based Approach for Investigating Environmental Monitoring Excursions
PPTX
Quality Risk Assessmsnt for Environmental Monitoring
PPTX
Cleanroom, Classification, Design and
PPTX
EMG Reconnecting with Water
PDF
mas 100
PPT
Compendial requirements for particle testing 2014
PDF
Fresh Thinking in Flexible Film API Containment
PDF
Parenteral products
PDF
4. Design, Trust & Control of Sterile Manufacturing (Observations)
PDF
Standard methods
PDF
PPTX
Ipqc for parenterals
PDF
Sterile area
PDF
Validation of sterelization_equipment
PPTX
Visual inspection
PPT
STERILE PROCESS OF VALIDATION
PPTX
WHO Guidance on HVAC Systems for Non Sterile Pharmaceuticals
PDF
Microbial limit tests I.P By Dr.P.Srinivas Jangaon institute of pharmaceutica...
PPTX
Visual inspection of parenteral products
Environmental monitoring
A Risk-Based Approach for Investigating Environmental Monitoring Excursions
Quality Risk Assessmsnt for Environmental Monitoring
Cleanroom, Classification, Design and
EMG Reconnecting with Water
mas 100
Compendial requirements for particle testing 2014
Fresh Thinking in Flexible Film API Containment
Parenteral products
4. Design, Trust & Control of Sterile Manufacturing (Observations)
Standard methods
Ipqc for parenterals
Sterile area
Validation of sterelization_equipment
Visual inspection
STERILE PROCESS OF VALIDATION
WHO Guidance on HVAC Systems for Non Sterile Pharmaceuticals
Microbial limit tests I.P By Dr.P.Srinivas Jangaon institute of pharmaceutica...
Visual inspection of parenteral products
Ad

Similar to Environmental monitoring - viable particle sampling (20)

PDF
1116 Added.pdf
PDF
Bioaerosol Sampling - Methods Of Analysis
PPTX
Best Sampling Practices Webinar – USP <797> Compliance & Environmental Monito...
PPTX
New Microsoft PowerPoint Presentation - 11.08.23.pptx
PPTX
Air Monitoring by Passive Sampling (lab).pptx
PPT
AIR_Microbiology_P1nohhcuhuguihihihi.ppt
PPTX
MICROBIAL CONTAMINATION IN HERBS AND THEIR FORMULATIONS
PDF
A Brief Overview on Active Air Sampling Procedure for Environment Monitoring
PPTX
Microbiological sampling of air
PPTX
Environmental monitoring
PDF
Bioburden
PDF
STANDARD OPERATING PROCEDURES FOR PARENTERAL DOSAGE FORM PREPARATION
PDF
Mb usp 797
PDF
Environmental Monitoring in operation mm
PPT
Aseptic processing
PPTX
3. Antimicrobial Effectiveness Final.pptx
PDF
7 Steps to an Effective Environmental Monitoring Plan
PPTX
aan ppt.pptx
PPTX
microbial limit testdfffffffffffffff.pptx
PDF
Pda book table of contents-environmental monitoring a comprehensive handbook ...
1116 Added.pdf
Bioaerosol Sampling - Methods Of Analysis
Best Sampling Practices Webinar – USP <797> Compliance & Environmental Monito...
New Microsoft PowerPoint Presentation - 11.08.23.pptx
Air Monitoring by Passive Sampling (lab).pptx
AIR_Microbiology_P1nohhcuhuguihihihi.ppt
MICROBIAL CONTAMINATION IN HERBS AND THEIR FORMULATIONS
A Brief Overview on Active Air Sampling Procedure for Environment Monitoring
Microbiological sampling of air
Environmental monitoring
Bioburden
STANDARD OPERATING PROCEDURES FOR PARENTERAL DOSAGE FORM PREPARATION
Mb usp 797
Environmental Monitoring in operation mm
Aseptic processing
3. Antimicrobial Effectiveness Final.pptx
7 Steps to an Effective Environmental Monitoring Plan
aan ppt.pptx
microbial limit testdfffffffffffffff.pptx
Pda book table of contents-environmental monitoring a comprehensive handbook ...

More from Jerry Fahrni (20)

PPTX
The Future of Pharmacy: Using Technology to Drive Practice Change
PPTX
Secondary Engineering Controls
PPTX
The Basics of Primary Engineering Controls
PPTX
Cleaning and Disinfecting iv Hoods and Rooms
PPTX
Environmental Monitoring - Glove Fingertip Sampling
PPTX
Pharmacy cleanroom terminology
PPTX
Environmental monitoring - temperature and pressure
PPTX
Pharmacy Cleanroom Basics
PPTX
Understanding Beyond-Use Dating for Sterile Compounds
PPTX
Pharmacy CSP Preparation: Personnel Garbing and Gloving
PPTX
Minimizing IV Admixture Errors
PPTX
USP 797 CSP Risk Categories
PPTX
Compounding personnel
PPTX
Introduction to USP General Chapter 797
PPTX
Help Navigating the Sea of Bar-Code Medication Preparation Technologies (BCMP)
PPTX
Evolution of practice in an age of information
PPT
The real work starts after implementation
PPTX
How Rounds Reports and Mobile Computing Support the Role of the Clinical Phar...
PPT
KDHCD Pharmacy Automation
PPT
Cloud computing and health care - Facing the Future
The Future of Pharmacy: Using Technology to Drive Practice Change
Secondary Engineering Controls
The Basics of Primary Engineering Controls
Cleaning and Disinfecting iv Hoods and Rooms
Environmental Monitoring - Glove Fingertip Sampling
Pharmacy cleanroom terminology
Environmental monitoring - temperature and pressure
Pharmacy Cleanroom Basics
Understanding Beyond-Use Dating for Sterile Compounds
Pharmacy CSP Preparation: Personnel Garbing and Gloving
Minimizing IV Admixture Errors
USP 797 CSP Risk Categories
Compounding personnel
Introduction to USP General Chapter 797
Help Navigating the Sea of Bar-Code Medication Preparation Technologies (BCMP)
Evolution of practice in an age of information
The real work starts after implementation
How Rounds Reports and Mobile Computing Support the Role of the Clinical Phar...
KDHCD Pharmacy Automation
Cloud computing and health care - Facing the Future

Recently uploaded (20)

PDF
NUTRITION THROUGHOUT THE LIFE CYCLE CHILDHOOD -AGEING
PDF
Priorities Critical Care Nursing 7th Edition by Urden Stacy Lough Test Bank.pdf
PPTX
Rheumatic heart diseases with Type 2 Diabetes Mellitus
PPTX
AI_in_Pharmaceutical_Technology_Presentation.pptx
PPT
Parental-Carer-mental-illness-and-Potential-impact-on-Dependant-Children.ppt
PDF
DAY-6. Summer class. Ppt. Cultural Nursing
PPTX
BLS, BCLS Module-A life saving procedure
PPTX
Medical aspects of impairment including all the domains mentioned in ICF
PPTX
Nancy Caroline Emergency Paramedic Chapter 8
PPTX
Immunity....(shweta).................pptx
PPT
Adrenergic drugs (sympathomimetics ).ppt
PDF
Myers’ Psychology for AP, 1st Edition David G. Myers Test Bank.pdf
PDF
Dr Masood Ahmed Expertise And Sucess Story
PPTX
Galactosemia pathophysiology, clinical features, investigation and treatment ...
PPTX
Current Treatment Of Heart Failure By Dr Masood Ahmed
PDF
2E-Learning-Together...PICS-PCISF con.pdf
PPTX
First Aid and Basic Life Support Training.pptx
PPTX
Trichuris trichiura infection
PDF
Dermatology diseases Index August 2025.pdf
PPTX
Genaralised anxiety disorder presentation
NUTRITION THROUGHOUT THE LIFE CYCLE CHILDHOOD -AGEING
Priorities Critical Care Nursing 7th Edition by Urden Stacy Lough Test Bank.pdf
Rheumatic heart diseases with Type 2 Diabetes Mellitus
AI_in_Pharmaceutical_Technology_Presentation.pptx
Parental-Carer-mental-illness-and-Potential-impact-on-Dependant-Children.ppt
DAY-6. Summer class. Ppt. Cultural Nursing
BLS, BCLS Module-A life saving procedure
Medical aspects of impairment including all the domains mentioned in ICF
Nancy Caroline Emergency Paramedic Chapter 8
Immunity....(shweta).................pptx
Adrenergic drugs (sympathomimetics ).ppt
Myers’ Psychology for AP, 1st Edition David G. Myers Test Bank.pdf
Dr Masood Ahmed Expertise And Sucess Story
Galactosemia pathophysiology, clinical features, investigation and treatment ...
Current Treatment Of Heart Failure By Dr Masood Ahmed
2E-Learning-Together...PICS-PCISF con.pdf
First Aid and Basic Life Support Training.pptx
Trichuris trichiura infection
Dermatology diseases Index August 2025.pdf
Genaralised anxiety disorder presentation

Environmental monitoring - viable particle sampling

  • 2. Environmental viable airborne particle testing is part of a good environmental sampling (ES) program designed to ensure that compounding area(s) maintain acceptably low viable particle levels.
  • 3. Your sampling plan for viable airborne testing should include sampling locations, collection methods, frequency, air volume to test, time of day testing will occur, and action levels
  • 4. Sampling for airborne viable particles must be conducted based on a risk assessment of your facilities compounding activities
  • 5. However, testing must occur at a minimum every 6 months in all compounding areas (PECs, buffer areas, ante areas, and areas adjacent to segregated compounding areas) as part of the recertification process
  • 6. Viable air sampling may be performed by properly training in-house personnel, or may be contracted to a qualified third party.
  • 7. Sampling must include multiple locations within each ISO Class 5 environment (PECs) and in the secondary engineering controls (ISO Class 7 buffer areas and ISO Class 8 ante- areas)
  • 8. Sampling must also be performed in segregated compounding areas at greatest risk of contamination (e.g., work areas near the ISO Class 5 environment, counters near doors, pass-through boxes, and so on)
  • 9. For low-, medium-, and high-risk level compounding, air sampling shall be performed at locations that are prone to contamination during compounding activities and during other activities such as staging, labeling, gowning, and cleaning.
  • 10. Locations must include zones of air backwash turbulence within laminar airflow workbenches (LAFW) and other areas where air backwash turbulence may enter the compounding area (doorways, in and around ISO Class 5 primary engineering control and environments)
  • 11. For low-risk level CSPs with 12-hour or less BUD prepared in an aseptic isolator located outside of a clean room that maintains an ISO Class 5 area in its interior, perform air sampling at locations inside the ISO Class 5 environment and other areas in close proximity to the ISO Class 5 environment
  • 12. It’s important when performing viable particle sampling to use both an appropriate collection method as well as an appropriate growth medium
  • 13. active air sampling to be performed using a volumetric impaction sampler. USP Chapter <797> calls for: *or other suitable media that supports the growth of fungi use of 2 media for air sampling: Soybean– Casein Digest Medium for bacteria and malt extract agar* for fungi in high-risk compounding areas
  • 14. Volumetric impaction samplers use a solid or adhesive medium, such as agar, for particle collection. Air is drawn into a sampler and accelerated, producing laminar air flow onto the collection surface (agar plate or contact plate filled with a suitable agar medium)
  • 15. Active sampling means that air samples are collected under working conditions, i.e. while compounding is taking pace
  • 16. It is suggested that the volume of air sampled be between 400mL and 1L* *subject to recommendations by the manufacturer of the sampling device and volume needed to meet limits of detection for ISO rating of area tested
  • 17. At the end of the air sampling activities, the microbial growth media plates are recovered and their covers are taped closed, and they are inverted and incubated at a temperature and period of time conducive to multiplication of microorganisms
  • 18. The TSA (a.k.a. Soybean-Casein Digest Agar Medium) used to test for bacteria should be incubated at 30°C to 35°C (86°F - 95°F) for 48 to 72 hours
  • 19. The Malt Extract Agar - or other suitable fungal media - should be incubated at 26°C to 30°C (79°F - 86°F) for 5 to 7 days *
  • 20. Growth media should be incubated outside the sterile prep area according to the manufacturer's recommendations
  • 21. Following incubation, the number of discrete colonies of microorganisms are counted and reported as colony-forming unit (cfu) per cubic meter (1000mL) of air and documented on an environmental sampling form CFU is a unit used to estimate the number of viable bacteria or fungal cells in a sample
  • 22. Action levels are determined on the basis of cfu data gathered at each sampling location and trended over time
  • 23. However, regardless of cfu count, the growth of highly pathogenic microorganisms1 must be immediately remedied with the assistance of a competent microbiologist, infection control professional or industrial hygienist 1. Gram-negative rods, coagulase positive staphylococcus, molds and yeasts can be potentially fatal to patients receiving CSPs
  • 24. Action levels for cfu count are listed below in Table 2 Table 2 adopted from: The United States Pharmacopeia, 37th rev., and The national formulary, 32nd ed. USP General Chapter <797>. Pharmaceutical Compounding - Sterile Preparations. Rockville, MD: The United States Pharmacopeial Convention; 2014.
  • 25. Any cfu count that exceeds its action level should prompt a re-evaluation of the adequacy of personnel work practices, cleaning procedures, operational procedures, and air filtration efficiency within the aseptic compounding location.
  • 26. Sources of contamination may include HVAC systems, damaged HEPA filters, and changes in personnel garbing or work practices.
  • 27. Areas exceeding action levels should be remediated back into compliance Review results Analyze lab data Compare to established levels Review organisms recovered Investigate cause Establish corrective actions Eliminate Problem Clean area and resample Implement procedures to prevent reoccurrence
  • 28. If an activity consistently shows elevated levels of microbial growth following corrective action, competent microbiology personnel should be consulted

Editor's Notes

  • #15: Settling of particles is dependent on particle size and may be influenced by air movement. Therefore, the number of cfu's on a settling plates may not always relate to concentrations of viable particles in the environment sampled.
  • #16: Settling of particles is dependent on particle size and may be influenced by air movement. Therefore, the number of cfu's on a settling plates may not always relate to concentrations of viable particles in the environment sampled.